SCHEMBL1032946

SCHEMBL1032946

COc1ccc(Cl)cc1-c1ccnc(Nc2ccccc2)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.60
PIK3CB P42338 5/20 0.60
PIK3CG P48736 5/20 0.60
AGPAT2 O15120 7/20 0.60
CDK2 P24941 2/20 0.56
JAK2 O60674 1/20 0.56
EGFR P00533 1/20 0.56
PTK2B Q14289 1/20 0.56
CDK9 P50750 5/20 0.55
AURKA O14965 2/20 0.55
GSK3B P49841 2/20 0.55
MAP4K4 O95819 1/20 0.55
ABL1 P00519 1/20 0.55
LCK P06239 1/20 0.55
MET P08581 1/20 0.55
PDGFRB P09619 1/20 0.55
FGFR1 P11362 1/20 0.55
FLT1 P17948 1/20 0.55
KDR P35968 1/20 0.55
FLT3 P36888 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4734845 0.85 CDK9 (0.63) PIK3CAPIK3CBPIK3CGCDK2CDK9
SCHEMBL14088787 0.79 JAK2 (0.59) PIK3CAPIK3CBPIK3CGCDK2JAK2
SCHEMBL3614861 0.78 ABL1 (0.61) PIK3CAPIK3CBPIK3CGCDK2JAK2
SCHEMBL1033197 0.77 ALDH1A1 (0.55) AGPAT2JAK2
SCHEMBL4737275 0.77 PIK3CA (0.52) PIK3CAPIK3CBPIK3CGCDK2CDK9
SCHEMBL1034516 0.76 SMN1; SMN2 (0.60) AGPAT2CDK2JAK2GSK3BMAP4K4
SCHEMBL12275494 0.76 PLK1 (0.70) PIK3CAPIK3CBPIK3CGCDK2JAK2
SCHEMBL14651244 0.76 PLK1 (0.58) PIK3CAPIK3CBPIK3CGCDK2EGFR
SCHEMBL8253883 0.76 ZAP70 (0.68) PIK3CAPIK3CBPIK3CGCDK2JAK2
SCHEMBL12764230 0.76 PRKCA (0.56) PIK3CAPIK3CBPIK3CGCDK2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed